Pneumocystis pneumonia (PCP)

From Aaushi
Jump to navigation Jump to search

Etiology

Epidemiology

Pathology

Clinical manifestations

Laboratory

Diagnostic procedures

Radiology

Complications

Differential diagnosis

Management

More general terms

Additional terms

References

  1. Manual of Medical Therapeutics, 28th edition, Ewald & McKenzie (eds) Little, Brown & Co, 1995, pg 332
  2. Harrison's Principles of Internal Medicine, 13th ed. Isselbacher et al (eds), McGraw-Hill Inc. NY, 1994, pg 908-910
  3. 3.0 3.1 Journal Watch vol 19 #22, pg 175, Nov 15, 1999
  4. 4.0 4.1 4.2 4.3 4.4 Medical Knowledge Self Assessment Program (MKSAP) 11, 14, 16, 17, 18, 19. American College of Physicians, Philadelphia 1998, 2006, 2012, 2015, 2018, 2021.
    Medical Knowledge Self Assessment Program (MKSAP) 19 Board Basics. An Enhancement to MKSAP19. American College of Physicians, Philadelphia 2022
  5. 5.0 5.1 Journal Watch 22(20):150, 2002 Yeni PG et al Antiretroviral treatment for adult HIV infection in 2002: updated recommendations of the International AIDS Society- USA Panel. JAMA 288:222, 2002 PMID: https://www.ncbi.nlm.nih.gov/pubmed/12095387
    Dybul M et al Guidelines for using antiretroviral agents among HIV- infected adults and adolescents. Ann Intern Med 137:381, 2002 PMID: https://www.ncbi.nlm.nih.gov/pubmed/12617573
    Dybul M et al Guidelines for Using Antiretroviral Agents Among HIV-Infected Adults and Adolescents Recommendations of the Panel on Clinical Practices for Treatment of HIV* MMWR Recomm Rep. 2002 May 17;51(RR-7):1-55 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/12027060 <Internet> http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5107a1.htm
    Masur H et al Guidelines for preventing opportunistic infections among HIV-infected persons--2002. Recommendations of the U.S. Public Health Service and the Infectious Diseases Society of America. Ann Intern Med 137:435, 2002 <PubMed> PMID: https://www.ncbi.nlm.nih.gov/pubmed/12617574 <Internet> http://www.cdc.gov/mmwr/preview/mmwrhtml/rr5108a1.htm
  6. 6.0 6.1 ARUP Consult: Pneumocystis jirovecii The Physician's Guide to Laboratory Test Selection & Interpretation https://arupconsult.com/content/pneumocystis-jirovecii
  7. Carmona EM, Limper AH. Update on the diagnosis and treatment of Pneumocystis pneumonia. Ther Adv Respir Dis. 2011 Feb;5(1):41-59. PMID: https://www.ncbi.nlm.nih.gov/pubmed/20736243
  8. 8.0 8.1 8.2 The NNT: Systemic Steroids for Pneumocystis Pneumonia (PCP,PJ) http://www.thennt.com/nnt/steroids-for-pcppj-pneumonia/
    Briel M, Bucher HC, Boscacci R, Furrer H. Adjunctive corticosteroids for Pneumocystis jiroveci pneumonia in patients with HIV-infection. Cochrane Database Syst Rev. 2006 Jul 19;(3):CD006150. PMID: https://www.ncbi.nlm.nih.gov/pubmed/16856118
  9. 9.0 9.1 Creemers-Schild D, Kroon FP, Kuijper EJ, de Boer MG. Treatment of Pneumocystis pneumonia with intermediate-dose and step-down to low-dose trimethoprim-sulfamethoxazole: lessons from an observational cohort study. Infection. 2015 Oct 15. [Epub ahead of print] PMID: https://www.ncbi.nlm.nih.gov/pubmed/26471512
  10. 10.0 10.1 Nunokawa T et al. Prophylactic effect of sulfasalazine against Pneumocystis pneumonia in patients with rheumatoid arthritis: A nested case-control study. Semin Arthritis Rheum 2019 Feb; 48:573 PMID: https://www.ncbi.nlm.nih.gov/pubmed/30057321 https://www.sciencedirect.com/science/article/pii/S0049017218300441
  11. 11.0 11.1 Lecuyer R et al. Characteristics and prognosis factors of Pneumocystis jirovecii pneumonia according to underlying disease: A retrospective multicentre study. Chest 2024 Jan 11; [e-pub]. PMID: https://www.ncbi.nlm.nih.gov/pubmed/38215935 https://journal.chestnet.org/article/S0012-3692(24)00022-9/fulltext